Agreement calls for identifying IDH gene mutations using Oncomine Precision Assay and the Ion Torrent Genexus System, a new turnkey, next-generation sequencing solution CARLSBAD, Calif. — Thermo Fisher Scientific today announced that it has expanded its strategic partnership with Agios Pharmaceuticals by adding the co-development of a second companion diagnostic (CDx) for oncology to their existing […]

Key Applications Include Oncology, Infectious Disease and Food Testing PARIS — Stilla Technologies, a leading provider of digital PCR (dPCR) solutions for high-precision genetic analysis, today launched the world’s first six-color digital PCR instrument, the six-color Prism. The instrument expands the multiplexing capabilities of the company’s digital PCR platform, the Naica™ System. The instrument has […]

End-to-end solution will enable mass/on-demand screening to support the re-opening of global economies. Group 42 (G42), a leading AI and Cloud Computing company based in the United Arab Emirates, and Oxford Nanopore Technologies, an advanced sequencing technology company based in the United Kingdom, announced today they have developed an unprecedented population-scale technology that rapidly and […]

Large-scale Manufacturing of Rapid Diagnostic Test Kit and Reagents to Enable Increased Testing Capacity for COVID-19 Worldwide First-ever FDA-authorized CRISPR-based Diagnostic to Launch This Month CAMBRIDGE, Mass. and CORALVILLE, Iowa  – Sherlock Biosciences and Integrated DNA Technologies (IDT) today announced the companies have entered into a strategic collaboration to enable large-scale manufacturing of the Sherlock™ […]

SAN DIEGO — Bionano Genomics, Inc. (NASDAQ: BNGO) today announced that the United States Patent and Trademark Office will issue US Patent No. 10,676,352 on June 9th, 2020. The patent, titled “NANONOZZLE DEVICE ARRAYS: THEIR PREPARATION AND USE FOR MACROMOLECULAR ANALYSIS,” covers the addition of a detector, such as a nanopore, to Bionano’s patented nanochannels.  […]

Vienna, Austria – Today Lexogen, the transcriptomics and next-generation sequencing company, launched the new TraPR Small RNA Isolation Kit. TraPR (Trans-Kingdom, Rapid, Affordable Purification of RISCs) is a breakthrough method that enables a gel free isolation of functional small RNAs (sRNAs) and allows for a cost-efficient, accurate, and highly reproducible analysis of sRNAs that carry important biological information. Regulatory […]

ANN ARBOR, Mich. — Swift Biosciences and Arbor Biosciences, a division of Chiral Technologies, jointly announced a partnership to offer a complete workflow for RNA-Seq library preparation and targeted enrichment of the SARS-CoV-2 genome. An enabling offering for epidemiological research and public health surveillance, the partnership leverages Swift’s patented Adaptase® technology within the Swift RNA […]

Supporting the pharmaceutical industry in providing potential life-saving treatments to patients faster MORRISVILLE, N.C.  – Q2 Solutions, a leading clinical trial laboratory services organization resulting from an IQVIA and Quest Diagnostics joint venture, today announced its partnership with Thermo Fisher Scientific to use the Ion Torrent Genexus System, the first fully integrated, next-generation sequencing (NGS) platform, to […]

HOUSTON — NuProbe, a global precision molecular diagnostics company, announces the world-wide exclusive in-license of two technologies from Rice University. The first, Non-Extensible Oligonucleotides (NEO), will allow NuProbe to provide much more rapid development of customized NGS panels, with turnaround time of less than 4 weeks. The second, Linear DNA Assembly (LDA) technology, improves the effective throughput […]

Expansion of the CAVATICA Platform to Australia Enables Harmonized Analysis of Geographically Separated and Jurisdictionally Protected Data Resources BOSTON —Seven Bridges, the industry-leading bioinformatics ecosystem provider, today announced a collaborative partnership between The Gabriella Miller Kids First Data Resource Center (Kids First DRC), ZERO Childhood Cancer (ZERO), the Children’s Brain Tumor Tissue Consortium (CBTTC), the […]